6533b7d5fe1ef96bd126529c
RESEARCH PRODUCT
Analysis of sterols by high-performance liquid chromatography/mass spectrometry combined with chemometrics
Maurizio AvernaDavide NotoKároly VékeyAnnamaria JakabLeopoldo CerauloKornél NagyFerenc PollreiszDavid Bongiornosubject
Settore MED/09 - Medicina InternaHypercholesterolemiaPilot ProjectsLathosterolMass spectrometryHigh-performance liquid chromatographyMass SpectrometryAnalytical ChemistryChemometricschemistry.chemical_compoundDesmosterolHumansHPLC/MS analysiChromatography High Pressure LiquidSpectroscopyChromatographyCholesterolCholestanolDesmosterolOrganic ChemistryExtraction (chemistry)cholesterol metaboliteDiscriminant AnalysisSitosterolsCholestanolSterolsCholesterolchemistrylipids (amino acids peptides and proteins)HPLCHydroxymethylglutaryl-CoA Reductase Inhibitorsdescription
A newly developed high-performance liquid chromatography/mass spectrometry (HPLC/MS) method has been successfully used to analyze plasma concentrations of various phytosterols (cholestanol and beta-sitosterol) and cholesterol metabolites (desmosterol and lathosterol). This was based on an unusual solvent combination of water/methanol vs. methanol/acetone/n-hexane applied on a Purospher Star RP-18e (125 x 2 mm, 3 microm) column, which proved excellent for the separation, identification and quantification of plasma sterols. Simple solid-phase extraction preparation of plasma samples was performed, followed by the developed fast and robust HPLC separation. Results on four groups of people were compared, those with low, normal and high plasma cholesterol levels and those with high cholesterol levels on statin therapy, and the results were evaluated using linear discriminant analysis (LDA). Variable selection for LDA was achieved using backward removal selection. Highly discriminatory variables were the ratios of desmosterol to sitosterol and of lathosterol to total plasma cholesterol. The latter ratio was also excellent for distinguishing subjects on statin therapy. The success rate of classification was 100%. The present pilot study shows the potential of HPLC/MS analysis and chemometrics for studying cholesterol-related disorders and warrants future full-scale medical study.
year | journal | country | edition | language |
---|---|---|---|---|
2006-07-15 | Rapid Communications in Mass Spectrometry |